Alterity Therapeutics (ATHE) Enterprise Value Growth (5y) (2014 - 2025)

Alterity Therapeutics (ATHE) Enterprise Value Growth (5y) (2014 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Alterity Therapeutics 29.68 Bn 29.68 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -4.75%
Jun 30, 2025 -28.67%
Dec 31, 2024 22.20%
Jun 30, 2024 56.72%
Dec 31, 2023 1.24%
Jun 30, 2023 56.28%
Dec 31, 2022 -6.32%
Jun 30, 2022 -8.54%
Dec 31, 2021 -4.68%
Jun 30, 2021 -0.28%
Dec 31, 2020 -0.39%
Jun 30, 2020 25.99%
Dec 31, 2019 18.66%
Jun 30, 2019 4.12%
Dec 31, 2018 9.40%
Jun 30, 2018 -15.55%
Dec 31, 2017 -12.89%
Jun 30, 2017 -13.13%
Dec 31, 2016 -19.14%
Jun 30, 2016 -17.87%